title: [Prophylactic use of icatibant before tracheal intubation of a patient with hereditary angioedema type III. (A literature review of perioperative management of patients with hereditary angioedema type III)].
abstract: Type III hereditary angioedema is a rare familial disorder that has recently been described as a separate condition. Triggers for episodes of angioedema include surgery, dental procedures, and tracheal intubation maneuvers. Since episodes affecting the upper airway are potentially life-threatening, prophylactic treatment is recommended in these situations. The use of icatibant (Firazyr(®)), for prevention of angioedema prior to tracheal intubation, is reported in a patient with type iii hereditary angioedema. A literature review on the anesthetic management of this condition was conducted.
authors.affiliation: Servicio de Anestesiología y Reanimación, Hospital Universitario de Cruces, Baracaldo, Vizcaya, España. Electronic address: fib96@euskalnet.net.
authors.forename: F
authors.initials: F
authors.lastname: Iturri Clavero
authors.affiliation: Servicio de Anestesiología y Reanimación, Hospital Universitario de Cruces, Baracaldo, Vizcaya, España.
authors.forename: A
authors.initials: A
authors.lastname: González Uriarte
authors.affiliation: Servicio de Anestesiología y Reanimación, Hospital Universitario de Cruces, Baracaldo, Vizcaya, España; Departamento de Farmacología, Universidad del País Vasco, Leioa, Vizcaya, España.
authors.forename: G
authors.initials: G
authors.lastname: Tamayo Medel
authors.affiliation: Servicio de Alergología, Hospital de Basurto, Basurto, Vizcaya, España.
authors.forename: P M
authors.initials: PM
authors.lastname: Gamboa Setién
mesh_terms: D000328:Adult; D000402:Airway Obstruction / Q000188:drug therapy / Q000209:etiology; D001920:Bradykinin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D065094:Bradykinin B2 Receptor Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000556:secondary / Q000601:surgery; D002528:Cerebellar Neoplasms / Q000556:secondary / Q000601:surgery; D002744:Chlorpheniramine / Q000008:administration & dosage / Q000627:therapeutic use; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D056828:Hereditary Angioedema Type III / Q000150:complications*; D006801:Humans; D007442:Intubation, Intratracheal; D007819:Laryngeal Edema / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D019990:Perioperative Care / Q000379:methods*; D011183:Postoperative Complications / Q000188:drug therapy / Q000209:etiology; D019106:Postoperative Hemorrhage / Q000209:etiology; D011229:Preanesthetic Medication; D011899:Ranitidine / Q000008:administration & dosage / Q000627:therapeutic use; D012121:Respiration, Artificial; D012141:Respiratory Tract Infections / Q000150:complications / Q000628:therapy; D014139:Tracheostomy
chemical_list: D065094:Bradykinin B2 Receptor Antagonists; C018904:dexchlorpheniramine; D002744:Chlorpheniramine; C065679:icatibant; D003907:Dexamethasone; D011899:Ranitidine; D001920:Bradykinin
keywords: Anestesia; Anesthesia; Angioedema hereditario tipo iii; Bradiquinina; Bradykinin; Cuidado perioperatorio; Hereditary angioedema type iii; Icatibant; Intubación; Intubation; Perioperative care